A new era in the management of spinal metastasis

cancer locomo Life expectancy Spine Surgery Techniques and Technologies Spinal Metastases Population Neurosurgery Nursing FOS: Health sciences Pathology and Forensic Medicine Metastasis 03 medical and health sciences 0302 clinical medicine Health Sciences Management of Spinal Metastatic Tumors Paralysis Internal medicine RC254-282 Cancer Orthopedic surgery Quality of life (healthcare) Metastatic Epidural Spinal Cord Compression Rehabilitation Activities of daily living Neoplasms. Tumors. Oncology. Including cancer and carcinogens Pathophysiology of Lumbar Disc Degeneration and Treatment minimally invasive spine surgery Radiation therapy Spinal Fusion Environmental health spinal metastasis Oncology multidisciplinary approach Medicine Surgery Metastatic Spine Tumors preemptive treatment Physical therapy
DOI: 10.3389/fonc.2024.1374915 Publication Date: 2024-04-16T04:47:56Z
ABSTRACT
Despite the recent advances in cancer treatment, incidence of patients with spinal metastases continues to grow along total number patients. Spinal can significantly impair activities daily living (ADL) and quality life (QOL), compared other types bone metastases, as they are characterized severe pain paralysis caused by skeletal-related events. Reduced ADL also lead treatment limitations certain anticancer agents radiation therapy not compatible treatments; thus, leading a shorter expectancy. Consequently, maintaining ADLs is paramount, spine surgeons have an integral role play this regard. However, neurosurgeon, orthopedic Japan do proactive approach which may prevent them from providing appropriate when needed (clinical inertia). To overcome such endemic inertia, it essential for 1) understand be more actively involved musculoskeletal disorders (cancer locomo) patients; 2) adoption multidisciplinary (coordination meetings only attending oncologist but surgeons, radiologists, rehabilitation specialists, professionals) preemptive medication, radiotherapy, surgical treatment; 3) integration latest findings associated minimally invasive treatments that expanded indications improved outcomes. This heralds new era management metastases.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (127)
CITATIONS (7)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....